MRI Radiomics Model Predicts Survival in Colorectal Cancer With Liver Metastases
A multicenter study shows that a hybrid model combining MRI radiomics, delta features, and clinical variables predicts overall survival in ...
A multicenter study shows that a hybrid model combining MRI radiomics, delta features, and clinical variables predicts overall survival in ...
A meta-analysis of 17 studies finds that Helicobacter pylori infection is associated with worse overall and progression-free survival in cancer ...
A Swedish study of 133 patients shows that FDG-PET/CT response assessment after chemoradiotherapy strongly predicts recurrence and overall survival in ...
A large target trial emulation found that cancer patients on SSRIs while receiving immune checkpoint inhibitors had significantly lower two-year ...
A post hoc analysis of the CheckMate 9ER trial links early worsening of bone pain and sleep quality to higher ...
A two-stage estimation analysis of the CheckMate 9ER trial shows that removing the influence of subsequent therapy substantially enlarges the ...
The final results of the German CARO study show that carfilzomib-based regimens achieve high adherence, trial-consistent effectiveness, and stable quality ...
A multicenter study shows that grading the severity of microvascular invasion in resected liver tumors strongly predicts recurrence and survival ...
Post hoc analyses of the SIMPLIFY-1 and MOMENTUM phase 3 trials show that myelofibrosis patients treated with momelotinib who achieve ...
A retrospective cohort of 259 Colombian breast cancer patients with germline pathogenic variants found a ten-year overall survival of 75 ...
A pooled analysis of four clinical trials finds that liver metastases are a strong negative prognostic factor for chemotherapy-treated pancreatic ...
A six-year follow-up of more than 1,100 Japanese gastric cancer patients provides the first long-term survival figures stratified by clinical ...
A retrospective cohort study of 123 patients suggests the oral fluoropyrimidine S-1 may deliver longer overall survival than capecitabine as ...
A multicenter Central European real-world study finds sacituzumab govitecan delivers meaningful survival benefit and manageable toxicity in heavily pretreated metastatic ...
A systematic review of five real-world studies finds that a biweekly gemcitabine and nab-paclitaxel schedule matches standard survival outcomes in ...
A multicenter real-world study of 465 patients found that adding brain radiotherapy to first-line third-generation EGFR inhibitors improved survival in ...
A small Turkish retrospective study found the MSKCC nomogram discriminated survival better than Sarculator in extremity soft tissue sarcoma, though ...
A real-world study of 214 patients finds that adding Bevacizumab to Olaparib maintenance therapy significantly improves overall survival only in ...
Researchers built an explainable random survival forest model that predicts overall and cancer-specific survival in postoperative gastrointestinal stromal tumor patients, ...
A propensity score-matched study of 153 patients suggests adjuvant radiotherapy does not improve overall or recurrence-free survival in limb liposarcoma, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.